By Editor

I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…

Search Stock Profiles

Latest News

MSFT: Microsoft Stock – Buy or Sell This Tech Titan?

Microsoft (MSFT) is the chill tech uncle you secretly admire, vibing at $393.08 (MacroTrends) as of…

By Editor

META: Meta Platforms Stock – Buy or Sell This Social Star?

Meta Platforms (META) is the social media diva turned AI visionary, voguing at $585.71 (StockAnalysis.com) as…

By Editor

REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?

Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a…

By Editor

AMZN: Amazon Stock – Buy or Sell This Retail Rebel?

Amazon (AMZN) is the swaggering king of online chaos, chilling at $195.73 (LiteFinance) as of March…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

AMGN: Amgen – Buy or Sell This Biotech Bruiser?

Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…

By Editor
2 Min Read

The Biotech Bonanza: A Wild Ride Through the Stock Market Jungle

Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle gym of thrills, spills,…

By Editor
7 Min Read

ABNB: Airbnb Stock – Buy or Sell This Travel Trailblazer?

Airbnb (ABNB) is the travel renegade crashing couches at $128.80 (StockAnalysis.com) as of March 26, 2025. It’s the cool kid…

By Editor
2 Min Read